ESC Premium Access

Impact of diabetes on 5-year clinical outcomes in stable coronary artery disease, across multiple geographical regions and ethnicities. Insights from the CLARIFY registry

Topic: Epidemiology, Prognosis, Outcome

Congress Presentation

About the speaker

Doctor Koon-Hou Mak

Mak Heart Clinic, Singapore (Singapore)
0 follower

5 more presentations in this session

Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus - The MET-REMODEL trialM

Speaker: Professor C. Lang (Dundee, GB)


Association between insulin resistance and coronary plaque vulnerability in patients with acute coronary syndromes: insights from optical coherence tomography

Speaker: Doctor S. Wu (Beijing, CN)


Impact of statin treatment on the prevalence of lesion vulnerability and instability features in patients with diabetes mellitus - Insights from the COMBINE (FFR-OCT) Study

Speaker: Doctor B. Berta (Kecskemet, HU)


Sex differences in mortality and rates of cardiovascular disease in patients with diabetes

Speaker: Mr M. Malmborg (Copenhagen, DK)


Impact of chronic kidney disease on diabetic patients with stable coronary disease undergoing surgery, angioplasty or medical treatment in a ten-year follow-up.

Speaker: Mr E. Martins (Sao Paulo, BR)


Access the full session

There is no sweet spot in diabetes

Speakers: Doctor K. Mak, Professor C. Lang, Doctor S. Wu, Doctor B. Berta, Mr M. Malmborg...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb